Matt De Silva
Matt De Silva is the Co-Founder and CEO of Notable Labs. Notable is accelerating the process of determining which drugs or combinations are most likely to be effective for pediatric cancer patients. The company has built an automated laboratory that rapidly evaluates thousands of drug combinations on cancer cells relative to healthy cells. A report is generated which prioritizes the drugs that are most specifically active against cancer cells. Notable is actively focused on children with blood cancer, partnering with physician researchers at MD Anderson, Seattle Children’s, Stanford, University of Kansas, and UCSF, among others. Notable was founded in 2014 by Matt in an effort to find treatment options for his father who was diagnosed with Glioblastoma Multiforme, a deadly stage 4 brain cancer that recently claimed the lives of Beau Biden, John McCain, and Ted Kennedy. Headquartered in Foster City, California, the company employs more than 30 scientists and engineers and has raised over $22M from prominent venture capital firms such as Builders VC, First Round Capital, Founders Fund, Lightspeed Capital, and Y Combinator.